EPR22-116: The Efficacy of COVID-19 Vaccination in Patients Receiving Chemo and Immunotherapies
Matthew Rendo(Brooke Army Medical Center), Joshua Fenderson(Brooke Army Medical Center), Manuel Bermúdez Caballero(United States Air Force), Chung Ting Kou(Brooke Army Medical Center), Thomas F. Gibbons(United States Air Force), Jason F. Okulicz(Gilead Sciences (United States))
Cited by 0
Related Papers
Enhanced CD4+ T-Cell Recovery with Earlier HIV-1 Antiretroviral Therapy
|New England Journal of Medicine|2013|358
Clinical Outcomes of Elite Controllers, Viremic Controllers, and Long‐Term Nonprogressors in the US Department of Defense HIV Natural History Study
|The Journal of Infectious Diseases|2009|305
Epidemiology and clinical characteristics of elite controllers
|Current Opinion in HIV and AIDS|2011|176
Effect of HIV infection and antiretroviral therapy on immune cellular functions
|JCI Insight|2019|114
Persistent Low-level Viremia While on Antiretroviral Therapy Is an Independent Risk Factor for Virologic Failure
|Clinical Infectious Diseases|2019|110